Commentary With the seasonal increase in Covid infections in the Northern United States, vaccines are important to keep the death counts down. To save lives, nothing is more critical than to ensure mass vaccination of older people who haven’t yet had Covid. While the protection against infection and disease wanes a few months after vaccination, the protection…
It’s Time to Drop the Hysteria and Learn to Live With COVID
Commentary For most people, Omicron is a highly contagious cold. Lots will catch it, and most will get sniffles and a sore throat. Yes, even with Omicron, as with the flu, some people will get seriously ill, and a few will die. Masking, social distancing, capacity limits, lockdowns, curfews, and “vaccines” are not stopping the…
Research Indicates Vaccines Provide Reduced Effectiveness Against Omicron
January 7, 2022
admin
CCP (Chinese Communist Party) virusCCP VirusCOVID-19Omicron variantUSUS NewsVaccinesVaccines & Safety
0 Comment
The Omicron variant of SARS-CoV-2 is much more effective at infecting people vaccinated against the COVID-19 disease it causes, a review of research on the subject suggests. Research also indicates vaccination provides less protection against serious disease upon Omicron infection. The Omicron variant, first detected in South Africa in November, now constitutes the dominant strain…
Omicron Cases Spike in Germany’s Most Vaccinated State
Germany’s smallest and least populous federal state has the highest vaccination rate nationwide, but it is currently faced with the highest infection rate of any region in the country, spurred by the Omicron variant of the CCP (Chinese Communist Party) virus. The maritime state of Bremen, located in the north of Germany, has nearly 84…
Omicron May Help End the Pandemic This Winter
Commentary In the 1960s, measles was devastating in many parts of the world, with the child mortality rate as high as 50 percent. Scientists isolated the virus from patients and cultivated it in chicken embryo fibroblasts. This process, called the attenuation process, made the virus less virulent. Less virulent viruses are sometimes used as vaccines, known…
The Defenestration of Dr. Robert Malone
Commentary Dr. Robert Malone is an American virologist and immunologist who has dedicated his professional existence to the development of mRNA vaccines. In the 1980s, Malone worked as a researcher at the Salk Institute for Biological Studies, where he conducted studies on messenger ribonucleic acid (mRNA) technology. In the early 1990s, Malone collaborated with Jon…
CDC Sued for Withholding Post-Licensure V-safe Data on COVID-19 Vaccines
The Centers for Disease Control and Prevention (CDC) has been sued by the Informed Consent Action Network (ICAN), which claims the agency is improperly withholding COVID-19 v-safe data from the American public. In a statement on Dec. 29, the non-profit group said it had filed a lawsuit (pdf) against the public health agency and the United States Department…
COVID-19 Vaccine Mandates Fail the Jacobson Test
Commentary Americans are a freedom-loving lot. It is our founding ethos and we have defended it across the world on numerous occasions. At the same time, we have a strong tradition of social altruism and dedication to the common good, especially in times of crisis. Now that the Covid-19 pandemic has been with us for…
Austria Adds Another 10 Days to Unvaccinated-Only Lockdown
The Austrian government on Thursday extended a lockdown for unvaccinated individuals by another ten days ahead of a COVID-19 vaccine requirement that is expected to go into effect in early 2022. Austrians who chose not to get vaccinated against the CCP (Chinese Communist Party) virus will over the Christmas holidays, and up until New Year’s…
Development of ‘Omicron-Specific’ Shot Could Begin in Weeks: Moderna CEO
December 21, 2021
admin
AMERICABancelBusiness & EconomyBusinesses in COVID-19CCP VirusCOVID-19InternationalModernaUSUS NewsVaccinesVaccines & SafetyWorld
0 Comment
Moderna’s chief executive officer doesn’t expect any problems with the development of a booster shot against the latest strain of the CCP virus and hopes clinical trials can begin early next year. “It only needs minor adjustments for Omicron. I don’t expect any problems,” Stéphane Bancel told Swiss newspaper Tages-Anzeiger, likely referring to the company’s…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`